Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
American heart journal
Year: 2015, Volume: 170, Issue: 4, Pages: 675-682.e8 |
| ISSN: | 1097-6744 |
| Online Access: | Verlag, kostenfrei, Volltext: http://www.sciencedirect.com/science/article/pii/S0002870315004433
|
| Author Notes: | Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D.Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, and Keith A. A. Fox |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1515686329 | ||
| 003 | DE-627 | ||
| 005 | 20220812071213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150922s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ahj.2015.07.006 |2 doi | |
| 035 | |a (DE-627)1515686329 | ||
| 035 | |a (DE-576)445686324 | ||
| 035 | |a (DE-599)BSZ445686324 | ||
| 035 | |a (OCoLC)1340709674 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation |b the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial) |c Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D.Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, and Keith A. A. Fox |
| 264 | 1 | |c 2015 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.09.2015 | ||
| 700 | 1 | |a Bansilal, Sameer |0 (DE-588)1076803520 |0 (DE-627)835353370 |0 (DE-576)445686030 |4 oth | |
| 700 | 1 | |a Hacke, Werner |d 1948- |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 oth | |
| 773 | 0 | 8 | |i In |t American heart journal |d Amsterdam [u.a.] : Elsevier, 1925 |g 170(2015), 4, Seite 675-682.e8 |h Online-Ressource |w (DE-627)313061718 |w (DE-600)2003210-9 |w (DE-576)090883500 |x 1097-6744 |7 nnas |a Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial) |
| 773 | 1 | 8 | |g volume:170 |g year:2015 |g number:4 |g pages:675-682.e8 |g extent:8 |a Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial) |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0002870315004433 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150922 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 910000 |d 911100 |e 910000PH12021699X |e 911100PH12021699X |k 0/910000/ |k 1/910000/911100/ |p 9 | ||
| 999 | |a KXP-PPN1515686329 |e 2863364030 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1515686329","language":["eng"],"note":["Gesehen am 22.09.2015"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"oth","display":"Bansilal, Sameer","given":"Sameer","family":"Bansilal"},{"given":"Werner","family":"Hacke","role":"oth","display":"Hacke, Werner"}],"title":[{"title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation","subtitle":"the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)","title_sort":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation"}],"relHost":[{"title":[{"title":"American heart journal","subtitle":"AHJ","title_sort":"American heart journal"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)American heart journal","note":["Gesehen am 21.09.2020"],"recId":"313061718","language":["eng"],"pubHistory":["1.1925 -"],"titleAlt":[{"title":"AHJ"}],"part":{"year":"2015","issue":"4","pages":"675-682.e8","volume":"170","text":"170(2015), 4, Seite 675-682.e8","extent":"8"},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo.","dateIssuedDisp":"1925-","publisher":"Elsevier ; Mosby","dateIssuedKey":"1925"}],"id":{"zdb":["2003210-9"],"eki":["313061718"],"issn":["1097-6744"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D.Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, and Keith A. A. Fox"]},"id":{"doi":["10.1016/j.ahj.2015.07.006"],"eki":["1515686329"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}]} | ||
| SRT | |a EFFICACYAN2015 | ||